7 results about "Iron supplementation" patented technology

This invention relates to the field of biomedical technology, providing a phosphorylated peptide iron chelate of Yanbian cattle hemoglobin, its preparation method, and its applications. The Yanbian cattle hemoglobin phosphorylated peptide iron chelate is prepared from Yanbian cattle blood through enzymatic hydrolysis, phosphorylation, and iron chelation. Specifically, the phosphorylation step actively introduces strongly negatively charged phosphate groups into the Yanbian cattle hemoglobin peptide chain, serving as new and stronger metal ion coordination sites, thereby specifically enhancing its chelating ability for ferrous ions and the stability of the complex. The Yanbian cattle hemoglobin phosphorylated peptide iron chelate possesses high iron content and good gastrointestinal stability, showing broad application prospects in the preparation of a new generation of highly efficient and low-irritant iron supplements.

The application relates to the technical field of sialic acid application, in particular to application of sialic acid in promoting iron absorption of iron supplement agents. It is found for the first time that sialic acid with a daily intake of 0.8-3.5 mg / kg and ferrous iron with a daily intake of 0.2-0.5 mg / kg can promote the absorption of ferrous iron by human bodies. More specifically, the application claims an iron supplement agent containing ferrous iron drugs and sialic acid. The iron supplement agent provided by the application promotes iron supplement by compounding sialic acid and ferrous iron drugs, thereby improving the bioavailability of iron, regulating immunity, promoting intestinal health and achieving various biological activities while supplementing iron.

In an iron (II) citrate monohydrate, identified by the formula FeC6H6O7-H2O ( Ferrous citrate monohydrate or iron citrate (II) monohydrate), obtained according to a particular production method, citric acid and elemental iron are bound in a molecular complex where the iron is agglomerated in the citrate which moves to a cyclic form and the iron is bound to the O groups of the carboxylic groups 1 and 3 through ionic bonds, forming two enantiomers, D and L (R and S), both perfectly water-soluble and highly assimilable by the human body. Formula (L) & Formula (D). With a different absorption mechanism from traditional iron molecules, said iron citrate monohydrate is usable in pharmaceutical and / or nutraceutical and / or food compositions, in particular in the treatment and prevention of iron deficiency anemias and in general of all diseases and disorders associated with iron deficiency. The effectiveness is proven by several examples.

The present invention discloses a heme iron – glycine chelated iron supplement preparation, belonging to the technical field of nutritional and pharmaceutical preparations. The preparation employs a four-source composite of heme iron, glycine chelated iron, ferrous gluconate, and ferrous lactate, enabling iron supplementation via heme receptor absorption, amino acid chelation pathways, and ionic diffusion. This design overcomes the limitations of single iron sources, including gastrointestinal irritation and low absorption of inorganic iron, dietary inhibition of conventional organic iron, and the high cost or slow onset of novel iron sources. The four iron sources act synergistically to reduce free iron ions and integrate multiple absorption pathways. As a result, gastrointestinal irritation is minimized, and the inhibitory effects of phytic acid, oxalic acid, and tannins are reduced, enabling stable and efficient intestinal absorption. The preparation achieves non-irritating, highly bioavailable, and sustained iron supplementation.

This invention discloses a CS-SA bilayer microcapsule, its preparation method, and its application in encapsulating tuna protein peptides for chelated iron, belonging to the field of pharmaceutical technology. First, using tuna minced meat as raw material, tuna protein peptides for chelated iron are prepared through complex enzymatic hydrolysis and chelation reaction. Then, using sodium alginate as the wall material, single-layer microcapsules are prepared using a sharp-pore-coagulation method. Finally, using chitosan as the outer wall material, CS-SA bilayer microcapsules are prepared through electrostatic layer-by-layer self-assembly. The CS-SA bilayer microcapsules prepared by this invention have a dense structure, uniform particle size, and an encapsulation efficiency of up to 45.0%. They exhibit excellent sustained-release performance in simulated gastrointestinal fluid, with release stability significantly superior to single-layer microcapsules and commercially available iron supplements. This invention realizes the high-value utilization of tuna processing byproducts and provides a new approach for the development of iron supplements.

1. Name of the designed product: packaging set (iron supplement). 2. Use of the designed product: for product packaging. 3. Design points of the designed product: in the pattern. 4. Picture or photo best indicating the design points: front view of set 2. 5. The designed product is a thin product, omitting the left view, right view, top view, and bottom view of set 1. 6. Other circumstances needing explanation: The designed product is a set product, so it is used and sold as a set. Set 1 is an inner packaging bag, set 2 is an outer packaging box, and set 1 is packed into set 2 for sale and use.

The present invention falls within the technical field of iron supplement preparation, and relates more particularly to a process for preparing and applying a supplement based on a polysaccharide-iron complex derived from Auricularia auricula-judae, intended to supplement iron, improve iron deficiency anemia and strengthen immunity, comprising the following steps: preparation of raw materials, selection of iron-rich Auricularia auricula-judae as raw material; culture and optimization, engineering modification of fermented and cultured Auricularia auricula-judae; screening and selection of Auricularia auricula-judae strains with a high iron content;The beneficial effects are as follows: by constructing gene expression vectors, transforming fungal cells, and screening and identifying transformants with high synthetic capacity, the level of expression of genes related to the generation and conversion of the iron element is increased, allowing the cultivation of Auricularia auricula-judae varieties containing higher levels of iron, in order to improve the yield and production efficiency of the polysaccharide-iron complex.